This week The CRISPR Journal released the articles that people are talking about, and Asymmetrex’s article on p53 and CRISPR/Cas9 made the list. This article is free to read until February 7, 2019.
“I wish to suggest another explanation for the worrisome observations based on often overlooked properties of p53 as a regulator of postnatal tissue stem-cell kinetics. Unlike the DNA damage explanation, the second interpretation of the two reports also provides a simple solution for testing and application.”
Read the full article while it is available here.